What is the current valuation of the UK lymphedema treatment market?

The market valuation was $22.03 Million in 2024. Read More

What is the projected market size for the UK lymphedema treatment market by 2035?

The market is expected to reach $49.83 Million by 2035. Read More

What is the expected CAGR for the UK lymphedema treatment market during the forecast period 2025 - 2035?

The expected CAGR is 7.7% during the forecast period. Read More

Which segment had the highest valuation in the UK lymphedema treatment market in 2024?

The Secondary Lymphedema segment had a valuation of $13.22 Million in 2024. Read More

What are the primary treatment options available in the UK lymphedema treatment market?

The primary treatment options include Compression Devices & Bandaging, Laser Therapy, Drug Therapy, and Surgery. Read More

Which area of the body is most affected by lymphedema according to the market data?

The Lower Extremity segment had a valuation of $8.81 Million in 2024, indicating it is significantly affected. Read More

Who are the key players in the UK lymphedema treatment market?

Key players include LymphaTech, Tactile Medical, BSN Medical, Medi USA, Sigvaris, Juzo, Lymphedivas, and Haddenham Healthcare. Read More

What was the valuation of the Compression Devices & Bandaging segment in 2024?

The Compression Devices & Bandaging segment was valued at $8.81 Million in 2024. Read More

How does the market for Clinical Research Organizations compare to other end-users in 2024?

The Clinical Research Organizations segment was valued at $6.61 Million, indicating a notable presence among end-users. Read More

What is the projected growth trend for the Upper Extremity segment in the UK lymphedema treatment market?

The Upper Extremity segment is projected to grow from $7.02 Million in 2024 to $15.93 Million by 2035. Read More

UK Lymphedema Treatment Market

ID: MRFR/HC/49231-HCR

200 Pages

Nidhi Mandole

Last Updated: February 06, 2026

UK Lymphedema Treatment Market Research Report: Size, Share, Trend Analysis By Types (Primary Lymphedema, Secondary Lymphedema), By Affected Area (Lower Extremity, Upper Extremity, Genitalia), By Treatment (Compression Devices & Bandaging, Laser Therapy, Drug Therapy & Surgery), and By End-User (Hospitals and Clinics, Clinical Research Organizations, Research & Academic Institutes) - Growth Outlook & Industry Forecast 2025 To 2035

UK Lymphedema Treatment Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)7.7%

2024 Market Size$ 22.03 Million

2025 Market Size$ 23.73 Million

2035 Market Size$ 49.83 Million

Key Players

LymphaTech

Tactile Medical

BSN Medical

Medi USA

Sigvaris

Juzo

Trends

Rising Awareness and Education
Technological Advancements in Treatment
Personalized Treatment Approaches

Opportunities

Rising Demand for Home-Based Care
Government Initiatives and Funding
Advancements in Compression Therapy

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Food, Beverages & Nutrition, BY Type (USD Million)
  1. 4.1.1 Primary Lymphedema
  2. 4.1.2 Secondary Lymphedema
2. 4.2 Food, Beverages & Nutrition, BY Affected Area (USD Million)
  1. 4.2.1 Lower Extremity
  2. 4.2.2 Upper Extremity
  3. 4.2.3 Genitalia
3. 4.3 Food, Beverages & Nutrition, BY Treatment (USD Million)
  1. 4.3.1 Compression Devices & Bandaging
  2. 4.3.2 Laser Therapy
  3. 4.3.3 Drug Therapy
  4. 4.3.4 Surgery
4. 4.4 Food, Beverages & Nutrition, BY End-User (USD Million)
  1. 4.4.1 Hospitals and Clinics
  2. 4.4.2 Clinical Research Organizations
  3. 4.4.3 Research & Academic Institutes
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Food, Beverages & Nutrition
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Food, Beverages & Nutrition
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 LymphaTech (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Tactile Medical (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 BSN Medical (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Medi USA (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Sigvaris (CH)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Juzo (DE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Lymphedivas (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Haddenham Healthcare (GB)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 UK MARKET ANALYSIS BY TYPE
3. 6.3 UK MARKET ANALYSIS BY AFFECTED AREA
4. 6.4 UK MARKET ANALYSIS BY TREATMENT
5. 6.5 UK MARKET ANALYSIS BY END-USER
6. 6.6 KEY BUYING CRITERIA OF FOOD, BEVERAGES & NUTRITION
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF FOOD, BEVERAGES & NUTRITION
9. 6.9 DRIVERS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
10. 6.10 RESTRAINTS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
11. 6.11 SUPPLY / VALUE CHAIN: FOOD, BEVERAGES & NUTRITION
12. 6.12 FOOD, BEVERAGES & NUTRITION, BY TYPE, 2024 (% SHARE)
13. 6.13 FOOD, BEVERAGES & NUTRITION, BY TYPE, 2024 TO 2035 (USD Million)
14. 6.14 FOOD, BEVERAGES & NUTRITION, BY AFFECTED AREA, 2024 (% SHARE)
15. 6.15 FOOD, BEVERAGES & NUTRITION, BY AFFECTED AREA, 2024 TO 2035 (USD Million)
16. 6.16 FOOD, BEVERAGES & NUTRITION, BY TREATMENT, 2024 (% SHARE)
17. 6.17 FOOD, BEVERAGES & NUTRITION, BY TREATMENT, 2024 TO 2035 (USD Million)
18. 6.18 FOOD, BEVERAGES & NUTRITION, BY END-USER, 2024 (% SHARE)
19. 6.19 FOOD, BEVERAGES & NUTRITION, BY END-USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY AFFECTED AREA, 2025-2035 (USD Million)
  3. 7.2.3 BY TREATMENT, 2025-2035 (USD Million)
  4. 7.2.4 BY END-USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

UK Food, Beverages & Nutrition Market Segmentation

Food, Beverages & Nutrition By Type (USD Million, 2025-2035)

Primary Lymphedema
Secondary Lymphedema

Food, Beverages & Nutrition By Affected Area (USD Million, 2025-2035)

Lower Extremity
Upper Extremity
Genitalia

Food, Beverages & Nutrition By Treatment (USD Million, 2025-2035)

Compression Devices & Bandaging
Laser Therapy
Drug Therapy
Surgery

Food, Beverages & Nutrition By End-User (USD Million, 2025-2035)

Hospitals and Clinics
Clinical Research Organizations
Research & Academic Institutes

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”